Xoma | Passifs Courants





Passifs Courants Changement Date
AbbVie USD 39.39B 376M 2025-09
Agenus USD 287.13M 52.57M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Ardelyx USD 83.39M 1.67M 2025-09
aTyr Pharma USD 15.68M 148K 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Celldex Therapeutics USD 46.46M 13.5M 2025-09
Curis USD 19.37M 745K 2025-06
Eli Lilly USD 40.14B 1.12B 2025-09
Incyte USD 1.52B 176.44M 2025-12
MacroGenics USD 44.47M 5.47M 2025-09
Novartis USD 32B 286M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 51.44M 16.37M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Xoma USD 28.3M 6.81M 2025-09


Xoma Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.